Compare CVS Health Corp (CVS) vs Opendoor Technologies Inc (OPEN) Price & Performance

CVS Health trades at $94.70, down 1.01% with strong technical support at $93-$91 levels. The company reported robust Q2 2026 earnings of $2.58 per share, beating estimates by 38%, while raising full-year guidance. Revenue growth accelerated to 7.3% year-over-year, driven by Aetna's recovery and retail strength. Analyst consensus remains overwhelmingly bullish with 84% buy ratings and a $115.90 price target representing 22% upside potential.

CVS presents compelling value with a 0.29 P/S ratio and positive earnings momentum, though net margins remain thin at 1.18%. Key risks include 2027 PBM pressure and healthcare regulatory changes. The stock's current technical weakness near support levels offers potential entry point for long-term investors seeking exposure to integrated healthcare services.

Opendoor Technologies (OPEN) trades at $3.495, up 0.58% today, but remains in a bearish technical trend with weak fundamentals. Revenue declined to $4.37B in 2025, with a net loss of $1.30B and negative margins. Recent Q2 2026 earnings missed expectations, reflecting ongoing challenges in the housing market. Cash flow improved in 2025, but debt levels remain elevated. Analyst sentiment is mixed, with a consensus price target of $3.58.

The outlook is cautious due to persistent losses, high debt, and macroeconomic headwinds like interest rates. Opportunities exist if operational improvements materialize, but risks include further revenue declines and competitive pressure. Investors should weigh the potential for a turnaround against significant execution risks.